Development and validation of a simple model to predict functionally significant coronary artery disease in Chinese populations: A two-center retrospective study

• Published in: Heliyon Vol. 9; no. 10; p. e20643
• Main Authors: Shen, Wen-Qian, Du, Guo-Qing, Duan, Xin, Li, Yi-Tong, Chen, Shuang, Huang, Yu-Ming, Yang, Jun-Qing, Li, Li-Wen, Xue, Jing-Yi, Tian, Jia-Wei
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.10.2023; Elsevier
• Subjects: biomarkers; coronary artery disease; Functionally significant coronary artery disease; High-sensitivity cardiac troponin; hyperlipidemia; Left ventricular ejection fraction; model validation; nomogram; prediction; Prediction model; Quantitative flow ratio; retrospective studies; risk; risk assessment; taxonomic revisions; Functionally significant coronary artery disease; High-sensitivity cardiac troponin; Left ventricular ejection fraction; Quantitative flow ratio; Prediction model
• ISSN: 2405-8440; 2405-8440
• DOI: 10.1016/j.heliyon.2023.e20643

This study sought to derive and validate a simple model combining traditional clinical risk factors with biomarkers and imaging indicators easily obtained from routine preoperative examinations to predict functionally significant coronary artery disease (CAD) in Chinese populations. We developed five models from a derivation cohort of 320 patients retrospective collected. In the derivation cohort, we assessed each model discrimination using the area under the receiver operating characteristic curve (AUC), reclassification using the integrated discrimination improvement (IDI) and net reclassification improvement (NRI), calibration using the Hosmer-Lemeshow test, and clinical benefit using decision curve analysis (DCA) to derive the optimal model. The optimal model was internally validated by bootstrapping, and external validation was performed in another cohort including 96 patients. The optimal model including 5 predictors (age, sex, hyperlipidemia, hs-cTnI and LVEF) achieved an AUC of 0.807 with positive NRI and IDI in the derivation cohort. Moreover, the Hosmer-Lemeshow test showed a good fit, and the DCA demonstrated good clinical net benefit. The C-statistic calculated by bootstrapping internal validation was 0.798, and the calibration curve showed adequate calibration (Brier score = 0.179). In the external validation cohort, the optimal model performance was acceptable (AUC = 0.704; Brier score = 0.20). Finally, a nomogram based on this model was constructed to facilitate its use in clinical practice. A simple model combined clinical risk factors with hs-cTnI and LVEF improving the prediction of functionally significant CAD in Chinese populations. This attractive model may be a choice for clinicians to risk stratification for CAD.